Maternal-fetal Medicine
SR | The effect of parental leave on parents’ mental health
15 Feb, 2023 | 15:44h | UTCInvited Commentary: Paid parental leave and mental health: the importance of equitable policy design – The Lancet Public Health
News Release: Generous parental leave schemes protect against poorer mental health – Stockholm University / News Medical
Cohort Study | In utero exposure to ADHD medication does not seem to result in worse offspring neurodevelopmental outcomes
14 Feb, 2023 | 10:54h | UTCSummary: The authors conducted a study to investigate the long-term effects of in utero exposure to ADHD medication (methylphenidate, amphetamine, dexamphetamine, lisdexamphetamine, modafinil, atomoxetine, clonidine) on offspring. The study followed 1,068,073 liveborn singletons from 1998 to 2018 and compared the outcomes of children whose mothers continued or discontinued ADHD medication during pregnancy. The main outcomes were neurodevelopmental psychiatric disorders, impairments in vision or hearing, epilepsy, seizures, or growth impairment during childhood or adolescence. After adjustment for demographic and psychiatric characteristics of the mother, no increased risk of any developmental disorders was found in offspring exposed to ADHD medication compared to those not exposed. The results provide reassurance for women with ADHD who depend on medication and consider continuing it during pregnancy.
(By ChatGPT, reviewed and edited)
Article: In utero exposure to ADHD medication and long-term offspring outcomes – Molecular Psychiatry (link to abstract – $ for full-text)
Commentary from the author on Twitter (thread – click for more)
In-utero exposure to ADHD medication is not associated with long-term adverse neurodevelopmental disorders and growth restriction in the offspring.
Read the thread below ?on our new paper just published in @molpsychiatry
? https://t.co/MKZ0aeFnhU#ADHD— Kathrine Bang Madsen (@Kathrine_BaMa) February 9, 2023
Stillbirth after adolescent and young adult cancer: a population-based study
14 Feb, 2023 | 10:33h | UTCCommentary: Previous Cancer Treatment Not Tied to Higher Stillbirth Rate – HealthDay
RCT | Testing equivalence of two doses of intravenous iron to treat iron deficiency in pregnancy
14 Feb, 2023 | 10:31h | UTC
Development of a machine learning model for sonographic assessment of gestational age
14 Feb, 2023 | 10:30h | UTCCommentary: AI Models Have Higher Accuracy for Estimating Gestational Age – HealthDay
RCT | Azithromycin reduces the risk of maternal sepsis or death in women planning a vaginal birth
13 Feb, 2023 | 13:02h | UTCAzithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Single-dose antibiotic prevents maternal sepsis and death – NIH News
Commentaries:
In large study, a single antibiotic dose slashed rate of sepsis in childbirth – STAT
Dose of azithromycin found to cut risk of maternal death, sepsis in childbirth – CIDRAP
The Lancet Series | Breastfeeding 2023
13 Feb, 2023 | 12:52h | UTCHomepage: Breastfeeding 2023 – The Lancet
Editorial: Unveiling the predatory tactics of the formula milk industry
Breastfeeding: crucially important, but increasingly challenged in a market-driven world
Marketing of commercial milk formula: a system to capture parents, communities, science, and policy
Commentaries:
Expert reaction to review of formula baby milk – Science Media Centre
US infant pertussis incidence trends before and after implementation of the maternal Tdap vaccine
13 Feb, 2023 | 12:38h | UTCUS Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine – JAMA Pediatrics (free for a limited period)
Commentary: Maternal Tdap Vaccination Protects Youngest Infants From Pertussis – HealthDay
Commentary on Twitter
Study findings suggest that maternal #Tdap vaccination is associated with a reduction in #pertussis among infants younger than 2 months, the strategy’s target age group. https://t.co/a5h3z2zXY2
— JAMA Pediatrics (@JAMAPediatrics) February 7, 2023
POTS and Pregnancy: a review of literature and recommendations for evaluation and treatment
10 Feb, 2023 | 13:37h | UTC
Cohort Study | Adverse pregnancy outcomes and long-term risk of ischemic heart disease in mothers
9 Feb, 2023 | 14:02h | UTCNews Release: Five major adverse pregnancy outcomes associated with long term risks of ischemic heart disease – News Medical/BMJ
Commentary: Complications during pregnancy linked to a higher risk of heart disease, study finds – CNN
Related:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
All Hypertensive Disorders of Pregnancy Increase the Risk of Future Cardiovascular Disease
Gestational Hypertension and Future Risk of Cardiovascular Disease
RCT | Pregnancy and neonatal safety of PrEP for HIV prevention initiated during pregnancy vs. afterwards
9 Feb, 2023 | 13:55h | UTCPregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial – The Lancet HIV (link to abstract – $ for full-text)
Guideline | Fetal monitoring in labor
9 Feb, 2023 | 13:48h | UTCFetal monitoring in labour – National Institute for Health and Care Excellence
Guideline | Intrapartum care for healthy women and babies
9 Feb, 2023 | 13:49h | UTCIntrapartum care for healthy women and babies – National Institute for Health and Care Excellence
Review | The role of MRI in the diagnosis and prognostic evaluation of fetuses with congenital diaphragmatic hernia
9 Feb, 2023 | 13:40h | UTC
RCT | Outcomes in children of women with type 2 diabetes exposed to metformin vs. placebo during pregnancy
8 Feb, 2023 | 12:32h | UTCOutcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
M-A | Comparative effectiveness of prophylactic strategies for preeclampsia
2 Feb, 2023 | 14:42h | UTCComparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)
Commentary: Meta‐analysis reveals effective prophylactic strategies for preeclampsia – MDEdge
M-A | Effects of opioids administered via intravenous or epidural patient-controlled analgesia after cesarean section
1 Feb, 2023 | 12:55h | UTC
Review | Exercise during pregnancy: effects on birth weight and on the risks of gestational diabetes and preterm delivery
31 Jan, 2023 | 13:45h | UTCRelated:
Report | Tranexamic acid at cesarean delivery: drug-error deaths
31 Jan, 2023 | 13:39h | UTC
Risk and trajectory of premature ischemic CVD in women with a history of pre-eclampsia: a nationwide register-based study
30 Jan, 2023 | 01:08h | UTCRisk and trajectory of premature ischaemic cardiovascular disease in women with a history of pre-eclampsia: a nationwide register-based study – European Journal of Preventive Cardiology (free for a limited period)
News Release: Pre-eclampsia linked with four-fold higher risk of heart attack in decade after delivery – European Society of Cardiology
Commentaries:
Preeclampsia Increases Heart Attack, Stroke Risk for Up to 20 Years After Pregnancy – HCP Live
Preeclampsia in Pregnancy a Bad Sign for Women’s Future Heart Health – HealthDay
Related:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
All Hypertensive Disorders of Pregnancy Increase the Risk of Future Cardiovascular Disease
Gestational Hypertension and Future Risk of Cardiovascular Disease
RCT | Effect of second-stage pushing timing on postpartum pelvic floor morbidity
30 Jan, 2023 | 00:31h | UTCEffect of Second-Stage Pushing Timing on Postpartum Pelvic Floor Morbidity: A Randomized Controlled Trial – Obstetrics & Gynecology (free for a limited period)
Commentary on Twitter
How does timing of pushing in obstetrics impact future pelvic floor health? #freearticle https://t.co/VPZgVt8JnU pic.twitter.com/gSiTGN1Vdv
— The Green Journal (@greenjrnl) January 24, 2023
European guidelines on perinatal care: corticosteroids for women at risk of preterm birth
25 Jan, 2023 | 11:32h | UTC
RCT | Routine use of endometrial receptivity testing to guide the timing of frozen embryo transfer did not improve the rates of live birth
20 Jan, 2023 | 14:45h | UTCEffect of Timing by Endometrial Receptivity Testing vs Standard Timing of Frozen Embryo Transfer on Live Birth in Patients Undergoing In Vitro Fertilization: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary on Twitter
Study findings do not support routine use of receptivity testing to guide the timing of embryo transfer during in vitro fertilization. https://t.co/p8jqTpRAfV #Research
— JAMA (@JAMA_current) December 6, 2022
Gestational age at birth and cognitive outcomes in adolescence: population based full sibling cohort study
19 Jan, 2023 | 14:27h | UTCEditorial: Gestational age at birth and school performance – The BMJ
News Release: Premature birth linked to poorer school grades in adolescence – BMJ
Review | An FP’s guide to identifying—and treating—postpartum depression
19 Jan, 2023 | 13:56h | UTCAn FP’s guide to identifying—and treating—postpartum depression – Journal of Family Practice